The phosphoinositide 3-kinase/protein kinase B/cAMP response element-binding protein (PI3K/AKT/CREB) pathway has been identified as a critical regulator of neuronal survival, synaptic repair, and neuroprotection in stroke therapy (Dong et al., 2021b). This evidence concerns the gene AKT1 and stroke disorder.